Thermo Fisher Scientific (TMO) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Thermo Fisher Scientific (TMO) is Neutral.

The composite score behind that read is +0.08, weighing +0.23 of bullish evidence against -0.19 bearish.

Thermo Fisher Scientific last closed at $658.02, +0.93% on the session.

Against the IVW growth benchmark the position is +0.13% over the forecast window.

The read is built from 15 underlying insights — 3 bullish and 12 bearish.

Agreement across those insights is 80%.

10 graded predictions for TMO so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Thermo Fisher Scientific in the 23rd percentile on valuation and the 69th percentile on return on equity, where 100 is best.

Thermo Fisher Scientific is classified under Health Care / Life Sciences Tools & Services, with a market capitalisation of $241.07B.

StockMap tracks Thermo Fisher Scientific as the 1st largest of the 41 companies it covers in the Life Sciences Tools & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 37 Neutral, 2 Moderate Outperform and 2 Moderate Underperform.

On that composite Thermo Fisher Scientific ranks 18th of 41 in the group, against a group median of +0.06.